PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company today announced that it will make four presentations on its infectious disease programs at IDWeek between October 7 – 11 in San Diego, CA.
Company researchers will report on research investigating geographical differences in clinical outcomes for patients with carbapenem-resistant Enterobacteriaceae (CRE). The Centers for Disease Control (CDC) consider CRE to be one of the three most urgent antimicrobial resistant infectious disease threats.
Help employers find you! Check out all the jobs and post your resume.
